Related Experiment Video

Updated: Aug 6, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

Recent advances in cystic fibrosis

I J Doull1

  • 1Cystic Fibrosis/Respiratory Unit, Department of Child Health, University Hospital of Wales, Cardiff CF14 4XW, UK. doullij@cf.ac.uk

Archives of Disease in Childhood
|June 23, 2001
PubMed

Insights

Cystic fibrosis life expectancy now exceeds 30 years, with newborns projected to reach over 40. Advances in understanding cystic fibrosis transmembrane conductance regulator (CFTR) and newborn screening improve patient outcomes.

Area of Science:

  • Medical Genetics
  • Pulmonology
  • Pediatrics

Background:

  • Cystic fibrosis (CF) median life expectancy has surpassed 30 years.
  • Projected life expectancy for newborn infants with CF is over 40 years.
  • Identification of the cystic fibrosis transmembrane conductance regulator (CFTR) gene has broadened the disease's clinical spectrum.

Purpose of the Study:

  • To highlight advancements in cystic fibrosis (CF) care.
  • To emphasize the benefits of newborn screening for CF.
  • To discuss current management strategies for CF.

Main Methods:

  • Review of current literature on CF outcomes and management.
  • Analysis of the impact of CFTR gene discovery on disease understanding.
  • Evaluation of evidence supporting newborn screening for CF.

Main Results:

  • Median life expectancy for CF patients is now over 30 years.
  • Newborns with CF are projected to live beyond 40 years.
  • CFTR gene identification has expanded the recognized clinical presentations of CF.

Conclusions:

  • Newborn screening for cystic fibrosis offers significant advantages.
  • Specialist care is crucial for optimizing outcomes in CF patients.
  • Effective CF management involves optimizing nutrition and preventing lung infections.

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...